Eli Lilly has morphed from a reliable pharma giant into a biotech powerhouse riding blockbuster success. Mounjaro and ...

Eli Lilly is making waves by acquiring SiteOne Therapeutics for up to $1 billion, eyeing a non-opioid chronic pain treatment.

Eli Lilly will buy privately held SiteOne Therapeutics in a deal worth as much as $1 billion, the companies said on Tuesday, ...

"We are introducing Wegovy (injectable Semaglutide 2.4 mg) this year, which offers full therapeutic strengths of semaglutide ...

Article originally published by. FE fundinfo is not responsible for its content or accuracy and may not share the author’s views. News and research are not personal recommendations to deal. All ...

ALPHARETTA, Ga. (AP) — ALPHARETTA, Ga. (AP) — Agilysys Inc. (AGYS) on Monday reported fiscal fourth-quarter profit of $3.9 million. The Alpharetta, Georgia-based company said it had net income of 14 ...

The trading activity, as per PrimeMFDatabase.com, has revealed a strong appetite for tech stocks, with significant exits from ...

CAMPBELL, Calif. (AP) — CAMPBELL, Calif. (AP) — 8x8 Inc. (EGHT) on Monday reported a loss of $5.4 million in its fiscal fourth quarter. On a per-share basis, the Campbell, California-based company ...

Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... than-expected performance in the US and Japan during the final quarter, when Q4 dividends rose 7.3% on an ...

"We remain on track to submit the CTA for our lead RNA editing program, AX-0810 targeting NTCP for cholestatic diseases, in Q2 2025, with our first clinical data readout expected in Q4 - key ...

In April, ProQR announced the appointments of Dennis Hom as Chief Financial Officer and Cristina Lopez Lopez, MD, PhD as Chief Medical Officer. These key leadership appointments support the ...